Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income

Testing and treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are highly effective, high-impact interventions. This article aims to estimate the cost-effectiveness of scaling up these interventions by scenarios, regions, and income groups. We modeled costs and impacts of he...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2020-12, Vol.23 (12), p.1552-1560
Hauptverfasser:	Tordrup, David, Hutin, Yvan, Stenberg, Karin, Lauer, Jeremy A., Hutton, David W., Toy, Mehlika, Scott, Nick, Chhatwal, Jagpreet, Ball, Andrew
Format:	Artikel
Sprache:	eng
Schlagworte:	Ambition Antiviral Agents - economics Antiviral Agents - therapeutic use Antiviral drugs Cirrhosis Commodity prices Cost analysis Cost control Cost Savings - economics Cost Savings - statistics & numerical data Cost-Benefit Analysis cost-effectiveness DALY Developing Countries - economics Developing Countries - statistics & numerical data Disability adjusted life years Disease Eradication - economics Disease Eradication - methods Economic Evaluation Elimination GDP Gross Domestic Product Health care expenditures Hepatitis Hepatitis B Hepatitis B - diagnosis Hepatitis B - drug therapy Hepatitis B - economics Hepatitis B - prevention & control Hepatitis C Hepatitis C - diagnosis Hepatitis C - drug therapy Hepatitis C - economics Hepatitis C - prevention & control Hepatocellular carcinoma Humans Income - statistics & numerical data Infections Intervention Liver cancer Liver cirrhosis Medical treatment Quality-Adjusted Life Years Scaling Sensitivity analysis viral hepatitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!